The Use of Biochemical and Biophysical Tools for Triage of High‐Throughput Screening Hits – A Case Study with Escherichia coli Phosphopantetheine Adenylyltransferase
- 24 March 2010
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 75 (5) , 444-454
Abstract
High‐throughput screening is utilized by pharmaceutical researchers and, increasingly, academic investigators to identify agents that act upon enzymes, receptors, and cellular processes. Screening hits include molecules that specifically bind the target and a greater number of non‐specific compounds. It is necessary to ‘triage’ these hits to identify the subset worthy of further exploration. As part of our antibacterial drug discovery effort, we applied a suite of biochemical and biophysical tools to accelerate the triage process. We describe application of these tools to a series of 9‐oxo‐4,9‐dihydropyrazolo[5,1‐b]quinazoline‐2‐carboxylic acids (PQ) hits from a screen of Escherichia coli phosphopantetheine adenylyltransferase (PPAT). Initial confirmation of specific binding to phosphopantetheine adenylyltransferase was obtained using biochemical and biophysical tools, including a novel orthogonal assay, isothermal titration calorimetry, and saturation transfer difference NMR. To identify the phosphopantetheine adenylyltransferase sub‐site bound by these inhibitors, two techniques were utilized: steady‐state enzyme kinetics and a novel 19F NMR method in which fluorine‐containing fragments that bind the ATP and/or phosphopantetheine sites serve as competitive reporter probes. These data are consistent with PQs binding the ATP sub‐site. In addition to identification of a series of PPAT inhibitors, the described hit triage process is broadly applicable to other enzyme targets in which milligram quantities of purified target protein are available.Keywords
This publication has 23 references indexed in Scilit:
- Promiscuous Aggregate-Based Inhibitors Promote Enzyme UnfoldingJournal of Medicinal Chemistry, 2009
- Phosphopantetheine Adenylyltransferase from Escherichia coli : Investigation of the Kinetic Mechanism and Role in Regulation of Coenzyme A BiosynthesisJournal of Bacteriology, 2007
- Scripps FloridaNature Chemical Biology, 2007
- Drugs for bad bugs: confronting the challenges of antibacterial discoveryNature Reviews Drug Discovery, 2006
- NIH Molecular Libraries InitiativeScience, 2004
- Invited Perspective: Screening in Academe: A Perspective on Implementation of University-Based Small Molecule ScreeningSLAS Discovery, 2003
- A Novel Adenylate Binding Site Confers Phosphopantetheine Adenylyltransferase Interactions with Coenzyme AJournal of Bacteriology, 2003
- A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput ScreeningJournal of Medicinal Chemistry, 2002
- The crystal structures of phosphopantetheine adenylyltransferase with bound substrates reveal the enzyme’s catalytic mechanism 1 1Edited by K. NagaiJournal of Molecular Biology, 2002
- Purification and Characterization of Phosphopantetheine Adenylyltransferase from Escherichia coliJournal of Biological Chemistry, 1999